Home » Topics » Regulatory

Regulatory
RSS

Bristol-Myers Squibb and AstraZeneca gain European approval for dapagliflozin

Nov. 15, 2012

FDA approves Pfizer's Xeljanz for rheumatoid arthritis

Nov. 8, 2012

Glybera gene therapy approved by the European Commission

Nov. 5, 2012

FDA grants first approval to ocriplasmin

Oct. 18, 2012

FDA approves Abraxane for NSCLC

Oct. 15, 2012

FDA approves Cystaran for corneal cystine crystals

Oct. 5, 2012

Novo Nordisk's insulin degludec obtains first approval

Oct. 2, 2012

Dacogen gains approval in the E.U. for acute myeloid leukemia

Oct. 2, 2012

Suini approved in Japan for type 2 diabetes

Oct. 2, 2012

Plavix gets Japanese approval for additional indication

Oct. 2, 2012